siRNA, Anti-TSG101, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21752WQ-2OMe)

The product SIRGT21752WQ-2OMe is a type of small interfering RNA (siRNA) that targets TSG101 gene and regulates the expression of gene. The siRNA interferes with the expression of TSG101 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_006292.3
Alternative Names TSG10; VPS23
Related Diseases Breast cancer
Purification HPLC
Target Gene
Gene ID 7251
Uniprot ID Q99816
Sub Cat Target Species Modification Scale  
SIRGT22752WQ-2F TSG101 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23752WQ-2MOE TSG101 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24752WQ-LNA TSG101 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21752WQ-RB TSG101 Human Ribo-modified Inquiry
SIRGT22752WQ-BB TSG101 Human Backbone-modified Inquiry

Related Products